GlaxoSmithKline Pharmaceuticals Ltd Generic : Hepatitis A Vaccine
906.00 720HM 1vial
â€¢ Central Nervous System:
Headache and tiredness.
â€¢ Local: Redness, soreness, swelling, redness, or warmth at the injection site and indurations at injection site.
â€¢ Miscellaneous: Loss of appetite, mild fever, nausea and transient soreness.
IM- Single dose of 0.5 or 1 ml depending on the product and patient's age. Give booster dose 6-12 months after the initial dose. Give via subcutaneous administration in haemophiliacs.
It comes as a solution for injection administered by a health care provider into the large muscle.
Severe immunodeficiency, allergic reaction (e.g., anaphylaxis) after a previous dose of any hepatitis A-containing vaccine, or to any component of Hepatitis A vaccine including neomycin.
Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 months after stopping treatment.
Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressant or HIV positive.
â€¢ Hepatitis A vaccine becomes effective after a period of at least 2 weeks. A second dose is administered 6 to 12 months after the first dose.
â€¢ It should not be used in children younger than 12 months old.
â€¢ Alcohol or disinfectant used for cleaning the skin prior to injection should be allowed to evaporate completely before vaccination to prevent vaccine inactivation.
â€¢ Caution needed for patients with history of illnesses or infections, blood disorders, immune system disorders, any allergies, pregnancy and breastfeeding.
For IM injection only. Not for IV or intradermal administration.
It is usually handled and stored by a health care provider.
Subscribe to our Free Newsletters!